| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |